Over the past year, you’ve most likely heard about CBD, or cannabidiol, in the news. The market for CBD is growing so rapidly that it’s predicted to surpass $15 billion by 2026. CBD can be applied directly to the skin or taken orally. Although it comes from the cannabis plant, it is non-intoxicating like THC, […]
Category: Prescription Drugs
Statistics regarding the current opioid crisis in the U.S. continue to indicate cause for alarm in comparison to previous years. According to the National Institute of Drug Abuse, a subset of the U.S. National Institutes of Health (NIH), an estimated 115 people in the U.S. die every day from opioid-related overdoses as of March 2018. […]
Manage specialty drug costs with these approaches.
Opioids have extensive histories as both prescribed and illicit drugs, and the fundamental challenge they present – as uniquely powerful analgesics that are nevertheless highly addictive – has long bedeviled the healthcare sector.
Unlike national programs such as Supplemental Security Income and state-federal partnerships like Medicaid, the structure and the funding of WC initiatives are entirely determined by statehouses.
Physicians are working toward a consensus on appropriate opioid prescription practices while navigating structural challenges to consistent and safe prescribing.
The culture of prescription drugs is slowly evolving so that opioids are used in quantities and therapies reflecting their safety profiles.
Years in the making, the opioid epidemic now accounts for a majority of all drug overdoses in the country.
EBM is a major step forward from older systems of medicine such as humorism and unproven (but once commonplace) procedures such as bloodletting.
VBP is designed to improve accountability for treatments and align patient/plan payments accordingly.